Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.12 Million | -5.28 Million | -4.4 Million | -2.91 Million | -2.08 Million | -987.34 Thousand |
| Net Income | -4.5 Million | -6.24 Million | -3.64 Million | -2.28 Million | -2.21 Million | -1.86 Million |
| Depreciation & Amortization | 86.14 Thousand | 73.36 Thousand | 3209.00 | 672.00 | 801.00 | 1590.00 |
| Deferred income taxes | - | -209.09 Thousand | -60.95 Thousand | -353.95 Thousand | -202.83 Thousand | - |
| Stock-based compensation | - | 209.09 Thousand | 60.95 Thousand | 353.95 Thousand | 202.83 Thousand | - |
| Change in working capital | -796.01 Thousand | 669.61 Thousand | -821.71 Thousand | -989.85 Thousand | -74.88 Thousand | 651.02 Thousand |
| Other non-cash items | 1.05 Million | 209.76 Thousand | 60.7 Thousand | 354.08 Thousand | 205.58 Thousand | 229.99 Thousand |
| Investing Cash Flow | -2226.00 | -58.42 Thousand | -26.64 Thousand | -5000.00 | 977.00 | -3000.00 |
| Investments in PPE | -2226.00 | -17.63 Thousand | -14.4 Thousand | -5000.00 | - | -3000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -40.79 Thousand | -12.24 Thousand | - | - | - |
| Financing Cash Flow | -772.98 Thousand | -84.21 Thousand | 17.18 Million | 3.66 Million | 1.95 Million | -11 Thousand |
| Debt repayment | -633 Thousand | -64.64 Thousand | -2.1 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1.18 Million | -402 Thousand | -192 Thousand | -11 Thousand |
| Common Stock Issuance | 241.00 | 21.23 Thousand | 16.27 Million | 4.06 Million | 2.14 Million | -12.14 Thousand |
| Other Financing Activities | -79.99 Thousand | -105.45 Thousand | 6.3 Million | 3.66 Million | 1.95 Million | 12.14 Thousand |
| Accounts receivables | -2.04 Million | 680.34 Thousand | -825.43 Thousand | -1.01 Million | -58.64 Thousand | 403.58 Thousand |
| Accounts payables | 1.24 Million | -10.72 Thousand | 3716.00 | 28.51 Thousand | -16.23 Thousand | 247.43 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 9.25 Million | 14.6 Million | 1.84 Million | 1.1 Million | 1.24 Million | 2.22 Million |
| Cash at end of period | 3.38 Million | 9.25 Million | 14.6 Million | 1.84 Million | 1.1 Million | 1.24 Million |
| Capital Expenditure | -2226.00 | -17.63 Thousand | -14.4 Thousand | -5000.00 | - | -3000.00 |
| Effect of forex changes on cash | 31.02 Thousand | 80.42 Thousand | -187.00 | -2000.00 | -3000.00 | 14 Thousand |
| Net cash flow / Change in cash | -5.87 Million | -5.35 Million | 12.76 Million | 740 Thousand | -133 Thousand | -988 Thousand |
| Free Cash Flow | -5.12 Million | -5.3 Million | -4.41 Million | -2.92 Million | -2.08 Million | -990.34 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.5 Million | -3.37 Million | -1.12 Million | -564.62 Thousand | -3.33 Million | -6.24 Million |
| Depreciation & Amortization | 86.14 Thousand | 43.2 Thousand | 42.94 Thousand | 21.47 Thousand | 44.37 Thousand | 73.36 Thousand |
| Deferred income taxes | - | - | - | - | -492.85 Thousand | -209.09 Thousand |
| Stock-based compensation | - | - | 23.13 Thousand | 23.13 Thousand | 63.93 Thousand | 209.09 Thousand |
| Change in working capital | -796.01 Thousand | - | - | - | 340.17 Thousand | 669.61 Thousand |
| Other non-cash items | 1.05 Million | 1.83 Million | -2.37 Million | -1.25 Million | 1.02 Million | 209.76 Thousand |
| Investing Cash Flow | -2226.00 | -2226.00 | 14.2 Thousand | - | -3877.00 | -58.42 Thousand |
| Investments in PPE | -2226.00 | -2226.00 | - | - | -3877.00 | -17.63 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -40.79 Thousand |
| Financing Cash Flow | -772.98 Thousand | -687.43 Thousand | -85.55 Thousand | -42.77 Thousand | -70.14 Thousand | -84.21 Thousand |
| Debt repayment | -633 Thousand | -633 Thousand | - | - | - | -64.64 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 241.00 | 172.00 | 69.00 | - | -1.00 | 21.23 Thousand |
| Other Financing Activities | -79.99 Thousand | - | -42.77 Thousand | -42.77 Thousand | -35.07 Thousand | -105.45 Thousand |
| Accounts receivables | -2.04 Million | - | - | - | 340.17 Thousand | 680.34 Thousand |
| Accounts payables | 1.24 Million | - | - | - | - | -10.72 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 9.25 Million | 5.65 Million | 9.25 Million | - | 11.67 Million | 14.6 Million |
| Cash at end of period | 3.38 Million | 3.38 Million | 5.65 Million | -1.79 Million | 9.25 Million | 9.25 Million |
| Capital Expenditure | -2226.00 | -2226.00 | - | - | -3877.00 | -17.63 Thousand |
| Effect of forex changes on cash | 31.02 Thousand | - | 14.2 Thousand | 14.2 Thousand | 2064.00 | 80.42 Thousand |
| Net cash flow / Change in cash | -5.87 Million | -2.27 Million | -3.59 Million | -1.79 Million | -2.42 Million | -5.35 Million |
| Free Cash Flow | -5.12 Million | -1.58 Million | -3.54 Million | -1.77 Million | -2.35 Million | -5.3 Million |
ACE
GPIL
NANOFH
IDCBF
SEOJF
600336